Maximilian Diehn, Ph.D. - Publications

Affiliations: 
2004 Stanford University, Palo Alto, CA 
Area:
gene expression

222 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Shah AT, Azad TD, Breese MR, Chabon JJ, Hamilton EG, Straessler K, Kurtz DM, Leung SG, Spillinger A, Liu HY, Behroozfard IH, Wittber FM, Hazard FK, Cho SJ, Daldrup-Link HE, ... ... Diehn M, et al. A comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas. Molecular Cancer Therapeutics. PMID 34353895 DOI: 10.1158/1535-7163.MCT-20-0987  1
2021 Kurtz DM, Soo J, Co Ting Keh L, Alig S, Chabon JJ, Sworder BJ, Schultz A, Jin MC, Scherer F, Garofalo A, Macaulay CW, Hamilton EG, Chen B, Olsen M, Schroers-Martin JG, ... ... Diehn M, et al. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature Biotechnology. PMID 34294911 DOI: 10.1038/s41587-021-00981-w  1
2021 Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME, Barlesi F, Bivona T, Diehn M, Dive C, Dziadziuszko R, Leighl N, Malapelle U, Mok T, Peled N, Raez LE, et al. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer: A Consensus Statement from The International Association for the Study of Lung Cancer (IASLC). Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34246791 DOI: 10.1016/j.jtho.2021.06.017  1
2021 Alig S, Macaulay CW, Kurtz DM, Dührsen U, Hüttmann A, Schmitz C, Jin MC, Sworder BJ, Garofalo A, Shahrokh Esfahani M, Nabet BY, Soo J, Scherer F, Craig AFM, Casasnovas O, ... ... Diehn M, et al. Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002573. PMID 33909455 DOI: 10.1200/JCO.20.02573  1
2021 Foggetti G, Li C, Cai H, Hellyer JA, Lin WY, Ayeni D, Hastings K, Choi J, Wurtz A, Andrejka L, Maghini DG, Rashleigh N, Levy S, Homer R, Gettinger SN, ... Diehn M, et al. Genetic determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo. Cancer Discovery. PMID 33707235 DOI: 10.1158/2159-8290.CD-20-1385  1
2021 Chiou SH, Tseng D, Reuben A, Mallajosyula V, Molina IS, Conley S, Wilhelmy J, McSween AM, Yang X, Nishimiya D, Sinha R, Nabet BY, Wang C, Shrager JB, Berry MF, ... ... Diehn M, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 54: 586-602.e8. PMID 33691136 DOI: 10.1016/j.immuni.2021.02.014  1
2021 Varlotto JM, Sun Z, Ky B, Upshaw J, Katz SI, Fitzgerald TJ, Wakelee H, Diehn M, Mankoff DA, Lovly C, Belani C, Oettel K, Masters G, Ramalingam S, Pennell NA. A review of immunotherapy for stage 3 and metastatic NSCLC & the rationale for the ECOG-ACRIN EA5181 study. The Oncologist. PMID 33594771 DOI: 10.1002/onco.13725  1
2021 Aredo JV, Mambetsariev I, Hellyer JA, Amini A, Neal JW, Padda SK, McCoach CE, Riess JW, Cabebe EC, Naidoo J, Abuali T, Salgia R, Loo BW, Diehn M, Han SS, et al. Durvalumab for Stage III EGFR-Mutated Non-Small Cell Lung Cancer After Definitive Chemoradiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33588109 DOI: 10.1016/j.jtho.2021.01.1628  1
2020 Moding EJ, Liu Y, Nabet BY, Chabon JJ, Chaudhuri AA, Hui AB, Bonilla RF, Ko RB, Yoo CH, Gojenola L, Jones CD, He J, Qiao Y, Xu T, Heymach JV, ... ... Diehn M, et al. Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer. Nature Cancer. 1: 176-183. PMID 34505064 DOI: 10.1038/s43018-019-0011-0  1
2020 Aredo JV, Diehn M, Berry GJ, Wakelee HA. Targeted Treatment of Multiple Primary Lung Cancers Harboring Distinct EGFR or RET Alterations: A Case Report. Clinical Lung Cancer. PMID 33451914 DOI: 10.1016/j.cllc.2020.12.005  1
2020 Wisdom AJ, Mowery YM, Hong CS, Himes JE, Nabet BY, Qin X, Zhang D, Chen L, Fradin H, Patel R, Bassil AM, Muise ES, King DA, Xu ES, Carpenter DJ, ... ... Diehn M, et al. Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy. Nature Communications. 11: 6410. PMID 33335088 DOI: 10.1038/s41467-020-19917-0  1
2020 Avanzini S, Kurtz DM, Chabon JJ, Moding EJ, Hori SS, Gambhir SS, Alizadeh AA, Diehn M, Reiter JG. A mathematical model of ctDNA shedding predicts tumor detection size. Science Advances. 6. PMID 33310847 DOI: 10.1126/sciadv.abc4308  1
2020 Hellyer JA, Padda SK, Diehn M, Wakelee HA. Clinical implications of KEAP1-NFE2L2 mutations in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33307193 DOI: 10.1016/j.jtho.2020.11.015  1
2020 Pennell NA, Dillmon M, Levit LA, Moushey EA, Alva AS, Blau S, Cannon TL, Dickson NR, Diehn M, Gonen M, Gonzalez MM, Hensold JO, Hinyard LJ, King T, Lindsey SC, et al. American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002953. PMID 33290128 DOI: 10.1200/JCO.20.02953  1
2020 Dudley JC, Diehn M. Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA. Annual Review of Pathology. PMID 33228464 DOI: 10.1146/annurev-pathmechdis-012419-032604  1
2020 Binkley MS, Jeon YJ, Nesselbush M, Moding EJ, Nabet BY, Almanza D, Kunder C, Stehr H, Yoo CH, Rhee S, Xiang M, Chabon JJ, Hamilton E, Kurtz DM, Gojenola L, ... ... Diehn M, et al. KEAP1/NFE2L2 mutations predict lung cancer radiation resistance that can be targeted by glutaminase inhibition. Cancer Discovery. PMID 33071215 DOI: 10.1158/2159-8290.CD-20-0282  1
2020 Zhang N, Liang R, Gensheimer MF, Guo M, Zhu H, Yu J, Diehn M, Loo BW, Li R, Wu J. Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer. Theranostics. 10: 11707-11718. PMID 33052242 DOI: 10.7150/thno.50565  1
2020 Nabet BY, Esfahani MS, Moding EJ, Hamilton EG, Chabon JJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Almanza D, Stehr H, Gojenola L, Bonilla RF, Jin MC, ... ... Diehn M, et al. Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell. PMID 33007267 DOI: 10.1016/j.cell.2020.09.001  1
2020 Accomando WP, Rao AR, Hogan DJ, Newman AM, Nakao A, Alizadeh AA, Diehn M, Diago OR, Gammon DK, Haghighi A, Gruber HE, Jolly DJ, Ostertag D. Molecular and immunological signatures are related to clinical benefit from treatment with Vocimagene amiretrorepvec (Toca 511) and 5-fluorocytosine (Toca FC) in patients with glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32816892 DOI: 10.1158/1078-0432.Ccr-20-0536  1
2020 Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, et al. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nature Reviews. Clinical Oncology. PMID 32632268 DOI: 10.1038/S41571-020-0392-0  0.01
2020 Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Response Letter: Radiation therapy for COVID-19 pneumopathy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 149: 238-239. PMID 32505722 DOI: 10.1016/J.Radonc.2020.05.048  1
2020 Binkley MS, Koenig JL, Kashyap M, Xiang M, Liu Y, Sodji Q, Maxim PG, Diehn M, Loo BW, Gensheimer MF. Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume. Radiation Oncology (London, England). 15: 114. PMID 32429982 DOI: 10.1186/S13014-020-01546-Y  1
2020 Kirsch DG, Diehn M, Cucinotta FA, Weichselbaum R. Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 32413531 DOI: 10.1016/J.Radonc.2020.04.060  1
2020 Gentles AJ, Hui AB, Feng W, Azizi A, Nair RV, Bouchard G, Knowles DA, Yu A, Jeong Y, Bejnood A, Forgó E, Varma S, Xu Y, Kuong A, Nair VS, ... ... Diehn M, et al. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biology. 21: 107. PMID 32381040 DOI: 10.1186/S13059-020-02019-X  1
2020 Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, ... ... Diehn M, et al. Integrating genomic features for non-invasive early lung cancer detection. Nature. 580: 245-251. PMID 32269342 DOI: 10.1038/S41586-020-2140-0  1
2020 Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, ... ... Diehn M, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 32215577 DOI: 10.1001/Jamaoncol.2020.0147  1
2020 Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, ... ... Diehn M, et al. Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32046999 DOI: 10.1158/1078-0432.Ccr-19-3418  1
2020 Nabet BY, Esfahani MS, Hamilton EG, Chabon JJ, Moding EJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Stehr H, Goljenola L, Jin MC, Jeon Y, Tseng D, ... ... Diehn M, et al. Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2020-5666  1
2020 Luca BA, Steen CB, Azizi A, Matusiak M, Przybyl J, Neishaboori N, Pérez AE, Diehn M, Alizadeh AA, Rijn Mvd, Gentles AJ, Newman AM. Abstract 3443: Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors Cancer Research. 80: 3443-3443. DOI: 10.1158/1538-7445.Am2020-3443  1
2020 Esfahani MS, Mehrmohamadi M, Steen CB, Hamilton EG, King DA, Soo J, Macaulay C, Jin M, Kurtz DM, Nabet B, Moding E, Chabon J, Newman A, Diehn M, Alizadeh AA. Abstract 3388: Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity Cancer Research. 80: 3388-3388. DOI: 10.1158/1538-7445.Am2020-3388  1
2020 Steen CB, Luca B, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Kurtz D, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Alizadeh A, Newman AM. Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma Cancer Research. 80: 1557-1557. DOI: 10.1158/1538-7445.Am2020-1557  1
2020 Rahman SJ, Chu S, Zhao S, Zou Y, Hui A, Stricker T, Diehn M, Massion PP. Abstract 1137: Deep targeted and whole exome sequencing identifies driver mutations in the airway epithelium of individuals at high risk for lung cancer Cancer Research. 80: 1137-1137. DOI: 10.1158/1538-7445.Am2020-1137  0.01
2019 Chaudhuri AA, Chen K, Diehn M, Loo BW. Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors. Therapeutic Radiology and Oncology. 3. PMID 33880444 DOI: 10.21037/tro.2019.05.01  1
2019 Esfahani MS, Lee LJ, Jeon YJ, Flynn RA, Stehr H, Hui AB, Ishisoko N, Kildebeck E, Newman AM, Bratman SV, Porteus MH, Chang HY, Alizadeh AA, Diehn M. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications. 10: 5712. PMID 31836708 DOI: 10.1038/S41467-019-13392-Y  1
2019 Baek S, He Y, Allen BG, Buatti JM, Smith BJ, Tong L, Sun Z, Wu J, Diehn M, Loo BW, Plichta KA, Seyedin SN, Gannon M, Cabel KR, Kim Y, et al. Deep segmentation networks predict survival of non-small cell lung cancer. Scientific Reports. 9: 17286. PMID 31754135 DOI: 10.1038/S41598-019-53461-2  1
2019 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, ... ... Diehn M, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/J.Gastro.2019.10.039  1
2019 Chen B, Khodadoust MS, Olsson N, Wagar LE, Fast E, Liu CL, Muftuoglu Y, Sworder BJ, Diehn M, Levy R, Davis MM, Elias JE, Altman RB, Alizadeh AA. Predicting HLA class II antigen presentation through integrated deep learning. Nature Biotechnology. PMID 31611695 DOI: 10.1038/S41587-019-0280-2  1
2019 Jeong Y, Hellyer JA, Stehr H, Hoang NT, Niu X, Das M, Padda SK, Ramchandran K, Neal JW, Wakelee HA, Diehn M. Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31548347 DOI: 10.1158/1078-0432.Ccr-19-1237  1
2019 Moding EJ, Liang R, Lartey FM, Maxim PG, Sung A, Diehn M, Loo BW, Gensheimer MF. Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. Clinical Lung Cancer. PMID 31377143 DOI: 10.1016/J.Cllc.2019.05.015  1
2019 Hellyer JA, Stehr H, Das M, Padda SK, Ramchandran K, Neal JW, Diehn M, Wakelee HA. Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 134: 42-45. PMID 31319993 DOI: 10.1016/J.Lungcan.2019.05.002  1
2019 Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, ... ... Diehn M, et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. PMID 31280963 DOI: 10.1016/J.Cell.2019.06.011  1
2019 Hiniker SM, Sodji Q, Quon A, Gutkin PM, Arksey N, Graves EE, Chin FT, Maxim PG, Diehn M, Loo BW. FLT-PET-CT for the Detection of Disease Recurrence After Stereotactic Ablative Radiotherapy or Hyperfractionation for Thoracic Malignancy: A Prospective Pilot Study. Frontiers in Oncology. 9: 467. PMID 31214507 DOI: 10.3389/Fonc.2019.00467  1
2019 Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology. PMID 31061481 DOI: 10.1038/S41587-019-0114-2  1
2019 Prionas ND, von Eyben R, Yi E, Aggarwal S, Shaffer J, Bazan J, Eastham D, Maxim PG, Graves EE, Diehn M, Gensheimer MF, Loo BW. Increases in Serial Pretreatment F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. Advances in Radiation Oncology. 4: 429-437. PMID 31011689 DOI: 10.1016/J.Adro.2018.11.006  1
2019 Loo BW, Diehn M. SABR-COMET: harbinger of a new cancer treatment paradigm. Lancet (London, England). PMID 30982688 DOI: 10.1016/S0140-6736(19)30278-8  1
2019 Wang SXY, Zhang BM, Wakelee HA, Koontz MZ, Pan M, Diehn M, Kunder CA, Neal JW. Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib. Anti-Cancer Drugs. PMID 30762593 DOI: 10.1097/Cad.0000000000000765  1
2019 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, ... ... Diehn M, et al. Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801907. PMID 30753108 DOI: 10.1200/Jco.18.01907  1
2019 Ross JB, Merriott DJ, Alhumaid S, Schueler E, Ko RB, Bush K, Maxim PG, Gensheimer MF, Loo BW, Diehn M. Influence of Dose and Fractionation on Radiologic Lung Fibrosis after Stereotactic Ablative Radiotherapy (SABR) International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2430  1
2019 Benson K, Sandhu N, Zhang C, Ko RB, Toesca DAS, Eyben RV, Diehn M, Bush K, Maxim PG, Gensheimer MF, Soltys SG, Loo BW, Pollom E, Chang DT. Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2134  1
2019 Ko RB, Jani K, Sodji Q, Merriott DJ, Pickthorn W, Bush K, Maxim PG, Diehn M, Loo BW. Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.151  1
2019 Binkley MS, Stehr H, Moding EJ, Owen SG, Ko R, Maxim PG, Loo BW, Diehn M. Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1407  1
2019 Heidari N, Bagshaw HP, Diehn M, Snyder M, Buyyounouski MK. Molecular Profiling of Oligometastases and Artificial Intelligence-based Model for Predicting Treatment Outcome in Advance Prostate Cancer International Journal of Radiation Oncology Biology Physics. 104: 1195. DOI: 10.1016/J.Ijrobp.2019.05.057  0.01
2018 Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, ... ... Diehn M, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery. PMID 30578357 DOI: 10.1158/2159-8290.Cd-18-0825  1
2018 Nguyen KH, Stehr H, Zhou L, Nguyen AH, Hiep PN, Van Cau N, Duy PC, Thorp R, Wakelee HA, Diehn M, Neal JW. Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam. Journal of Global Oncology. 1-9. PMID 30422746 DOI: 10.1200/Jgo.18.00086  1
2018 Reid S, Newman AM, Diehn M, Alizadeh AA, Tibshirani R. Genomic Feature Selection by Coverage Design Optimization. Journal of Applied Statistics. 45: 2658-2676. PMID 30294060 DOI: 10.1080/02664763.2018.1432577  1
2018 Harris JP, Nwachukwu C, Qian Y, Pollom E, Loo BW, Das M, Diehn M. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 124: 76-85. PMID 30268484 DOI: 10.1016/J.Lungcan.2018.07.033  1
2018 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, ... ... Diehn M, et al. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785246. PMID 30125215 DOI: 10.1200/Jco.2018.78.5246  1
2018 Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, et al. F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29859786 DOI: 10.1016/J.Ijrobp.2018.03.045  1
2018 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, et al. GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research. PMID 29760045 DOI: 10.1158/0008-5472.Can-17-2928  1
2018 Moding EJ, Diehn M, Wakelee HA. Circulating tumor DNA testing in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 119: 42-47. PMID 29656751 DOI: 10.1016/J.Lungcan.2018.02.019  1
2018 Pinkham DW, Negahdar M, Yamamoto T, Mittra E, Diehn M, Nair VS, Keall PJ, Maxim PG, Loo BW. A Feasibility Study of Single-inhalation, Single-energy Xenon-enhanced CT for High-resolution Imaging of Regional Lung Ventilation in Humans. Academic Radiology. PMID 29606339 DOI: 10.1016/J.Acra.2018.03.006  1
2018 Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017768671. PMID 29504847 DOI: 10.1200/Jco.2017.76.8671  1
2018 Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of Pathology & Laboratory Medicine. PMID 29504834 DOI: 10.5858/Arpa.2018-0901-Sa  1
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh AA, Diehn M, van de Rijn M. Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29463554 DOI: 10.1158/1078-0432.Ccr-17-3704  1
2018 Lee J, Li B, Cui Y, Sun X, Wu J, Zhu H, Yu J, Gensheimer MF, Loo BW, Diehn M, Li R. A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29439884 DOI: 10.1016/J.Ijrobp.2018.01.006  1
2018 Rhee S, Chung JI, King DA, D'amato G, Paik DT, Duan A, Chang A, Nagelberg D, Sharma B, Jeong Y, Diehn M, Wu JC, Morrison AJ, Red-Horse K. Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease. Nature Communications. 9: 368. PMID 29371594 DOI: 10.1038/S41467-017-02796-3  1
2018 King M, Sensakovic WF, Maxim P, Diehn M, Loo BW, Xing L. Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis. Technology in Cancer Research & Treatment. 17: 1533034617749419. PMID 29343206 DOI: 10.1177/1533034617749419  1
2018 Jin MC, Schroers-Martin JG, Kurtz DM, Buedts L, Esfahani MS, Macaulay C, Sworder B, Soo J, Glover C, Roschewski M, Wilson WH, Dührsen U, Hüttmann A, Rossi D, Gaidano G, ... ... Diehn M, et al. Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma Blood. 132: 2838-2838. DOI: 10.1182/Blood-2018-99-119140  1
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh A, Diehn M, Rijn Mvd. Abstract A05: Circulating tumor DNA levels correlate with response to treatment in LMS patients Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A05  1
2018 Ross JB, Schueler E, Ko R, Bush K, Maxim PG, Gensheimer MF, Loo BW, Diehn M. Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR) International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1890  1
2018 Quaovi S, Ko R, Bush K, Binkley MS, Pickthorn W, Maxim PG, Gensheimer MF, Diehn M, Loo BW. Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1802  1
2017 Jiang D, Turner B, Song J, Li R, Diehn M, Le QT, Khatri P, Koong AC. Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes. Jco Precision Oncology. 2017. PMID 29888341 DOI: 10.1200/PO.16.00073  1
2017 Blakely CM, Watkins TBK, Wu W, Gini B, Chabon JJ, McCoach CE, McGranahan N, Wilson GA, Birkbak NJ, Olivas VR, Rotow J, Maynard A, Wang V, Gubens MA, Banks KC, ... ... Diehn M, et al. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nature Genetics. PMID 29106415 DOI: 10.1038/Ng.3990  1
2017 Aalipour A, Dudley JC, Park SM, Murty S, Chabon JJ, Boyle EA, Diehn M, Gambhir SS. Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. Clinical Chemistry. PMID 29038154 DOI: 10.1373/Clinchem.2017.278911  1
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, ... ... Diehn M, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.Cd-17-0716  1
2017 Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, ... Diehn M, et al. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28830717 DOI: 10.1016/J.Radonc.2017.08.007  1
2017 Lee J, Cui Y, Sun X, Li B, Wu J, Li D, Gensheimer MF, Loo BW, Diehn M, Li R. Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. European Radiology. PMID 28786009 DOI: 10.1007/S00330-017-4996-4  1
2017 Li B, Cui Y, Diehn M, Li R. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer. Jama Oncology. PMID 28687838 DOI: 10.1001/Jamaoncol.2017.1609  1
2017 Newman AM, Gentles AJ, Liu CL, Diehn M, Alizadeh AA. Data normalization considerations for digital tumor dissection. Genome Biology. 18: 128. PMID 28679399 DOI: 10.1186/S13059-017-1257-4  1
2017 Qian Y, Zhu H, Pollom EL, Durkee BY, Chaudhuri AA, Gensheimer MF, Diehn M, Shultz DB, Loo BW. Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology. PMID 28669706 DOI: 10.1016/J.Prro.2017.04.005  1
2017 Gensheimer MF, Bush K, Juang T, Herzberg B, Villegas M, Maxim PG, Diehn M, Loo BW. Practical workflow for rapid prototyping of radiation therapy positioning devices. Practical Radiation Oncology. PMID 28668669 DOI: 10.1016/J.Prro.2017.05.004  1
2017 Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, et al. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). Bmc Cancer. 17: 453. PMID 28662647 DOI: 10.1186/s12885-017-3455-6  1
2017 Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, et al. Randomized Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-small Cell Lung Cancer: NRG Oncology RTOG 0839. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28629896 DOI: 10.1016/J.Jtho.2017.06.007  1
2017 Harris JP, Patel MI, Loo BW, Wakelee HA, Diehn M. A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 108: 173-182. PMID 28625632 DOI: 10.1016/J.Lungcan.2017.03.017  1
2017 Scherer F, Kurtz DM, Diehn M, Alizadeh AA. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. PMID 28600337 DOI: 10.1182/Blood-2017-03-735639  1
2017 Pollom EL, Chin AL, Diehn M, Loo BW, Chang DT. Normal Tissue Constraints for Abdominal and Thoracic Stereotactic Body Radiotherapy. Seminars in Radiation Oncology. 27: 197-208. PMID 28577827 DOI: 10.1016/J.Semradonc.2017.02.001  1
2017 Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28460826 DOI: 10.1016/J.Radonc.2017.03.021  1
2017 Offin M, Chabon JJ, Razavi P, Isbell JM, Rudin CM, Diehn M, Li BT. Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA. Journal of Oncology. 2017: 4517834. PMID 28392802 DOI: 10.1155/2017/4517834  1
2017 Chuang JC, Stehr H, Liang Y, Das M, Huang J, Diehn M, Wakelee HA, Neal JW. ERBB2-mutated metastatic non-small cell lung cancer: response and resistance to targeted therapies. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28167203 DOI: 10.1016/J.Jtho.2017.01.023  1
2017 Kurtz DM, Scherer F, Jin M, Soo J, Craig A, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust M, Advani RH, Levy R, ... ... Diehn M, et al. Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma Blood. 130: 826-826. DOI: 10.1182/Blood.V130.Suppl_1.826.826  1
2017 Kurtz DM, Jin M, Soo J, Scherer F, Craig A, Chabon JJ, Schroers-Martin JG, Liu CL, Stehr H, Schmitz C, Duehrsen U, Hüttmann A, Cottereau AS, Meignan M, Casasnovas O, ... ... Diehn M, et al. Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study Blood. 130: 310-310. DOI: 10.1182/Blood.V130.Suppl_1.310.310  1
2017 Schroers-Martin JG, Scherer F, Soo J, Kurtz DM, Liu CL, Stehr H, Bru A, Natkunam Y, Diehn M, Nadel B, Roulland S, Alizadeh AA. Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis Blood. 130: 308-308. DOI: 10.1182/Blood.V130.Suppl_1.308.308  1
2017 Jin M, Kurtz DM, Esfahani MS, Soo J, Craig A, Scherer F, Stehr H, Schroers-Martin JG, Bangs CD, Cherry A, Natkunam Y, Roschewski M, Wilson WH, Duehrsen U, Hüttmann A, ... ... Diehn M, et al. Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes Blood. 130: 2747-2747. DOI: 10.1182/Blood.V130.Suppl_1.2747.2747  1
2017 Gentles AJ, Hui A, Feng W, Nair RV, Yu A, Shafiq M, Forgo E, Khuong A, Xu Y, Hoang CD, West RB, Rijn Mvd, Diehn M, Plevritis SK. Abstract LB-219: Higher levels of mast cells associate with favorable outcomes in non-small cell lung cancer and correlate with lower malignant cell proliferation Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-219  1
2017 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager J, Ayers K, Nair VS, Gentles A, Diehn M, Quon A, Napel S, Plevritis S. Abstract 4403: FDG uptake in human lung adenocarcinoma associated with invasion through the hexosamine biosynthesis pathway Cancer Research. 77: 4403-4403. DOI: 10.1158/1538-7445.Am2017-4403  1
2017 Jeong Y, Hoang N, Stehr H, Lovejoy A, Gentles A, Chaudhuri A, Loo B, Alizadeh A, Diehn M. Abstract 1034: Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance Cancer Research. 77: 1034-1034. DOI: 10.1158/1538-7445.Am2017-1034  1
2017 Gensheimer MF, Hong JC, Chang-Halpenny CN, Eclov N, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara W, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, et al. Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non–small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1695  1
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Zhou L, Liu CL, Scherer F, Kurtz DM, Esfahani MS, Say C, Carter JN, Merriott D, Dudley J, ... ... Diehn M, et al. S012) Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.048  1
2016 Wu J, Gensheimer M, Dong X, Rubin D, Napel S, Diehn M, Loo B, Li R. SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer. Medical Physics. 43: 3349. PMID 28046308 DOI: 10.1118/1.4955673  1
2016 Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, Stehr H, von Eyben R, Jiang D, Ellies LG, Koong AC, Diehn M, Rankin EB, Graves EE, Giaccia AJ. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nature Communications. 7: 13898. PMID 28008921 DOI: 10.1038/Ncomms13898  1
2016 Wang SX, Zhang BM, Wakelee H, Diehn M, Kunder CA, Neal JW. PS01.67: Case Series of MET Exon 14 Skipping Mutation-Positive Non-Small Cell Lung Cancers and Response to Crizotinib: Topic: Medical Oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S312-S313. PMID 27969534 DOI: 10.1016/J.Jtho.2016.09.102  1
2016 Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, ... ... Diehn M, et al. Molecular profiling of single circulating tumor cells from lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 27956614 DOI: 10.1073/Pnas.1608461113  1
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, ... ... Diehn M, et al. Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 13513. PMID 27841271 DOI: 10.1038/Ncomms13513  1
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, ... ... Diehn M, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science Translational Medicine. 8: 364ra155. PMID 27831904 DOI: 10.1126/Scitranslmed.Aai8545  1
2016 Lee JJ, Rothenberg ME, Seeley ES, Zimdahl B, Kawano S, Lu WJ, Shin K, Sakata-Kato T, Chen JK, Diehn M, Clarke MF, Beachy PA. Control of inflammation by stromal Hedgehog pathway activation restrains colitis. Proceedings of the National Academy of Sciences of the United States of America. PMID 27815529 DOI: 10.1073/Pnas.1616447113  1
2016 Cirujeda P, Dicente Cid Y, Muller H, Rubin D, Aguilera TA, Loo BW, Diehn M, Binefa X, Depeursinge A. A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT. Ieee Transactions On Medical Imaging. PMID 27740476 DOI: 10.1109/TMI.2016.2591921  1
2016 Chaudhuri AA, Lovejoy AF, Chabon JJ, Newman A, Stehr H, Say C, Aggarwal S, Carter JN, West RB, Neal JW, Wakelee HA, Loo BW, Alizadeh A, Diehn M. CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S41-S42. PMID 27675925 DOI: 10.1016/J.Ijrobp.2016.06.112  1
2016 King M, Xiong G, Maxim PG, Diehn M, Loo BW, Xing L. Vesselness-Based Deformable Registration Algorithms Can Reduce Landmark Errors in the Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S227. PMID 27675846 DOI: 10.1016/J.Ijrobp.2016.06.564  1
2016 Waliany S, Shultz DB, Gensheimer MF, Loo BW, Diehn M. Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S155. PMID 27675661 DOI: 10.1016/J.Ijrobp.2016.06.375  1
2016 Wu J, Gensheimer MF, Dong X, Rubin DL, Napel S, Diehn M, Loo BW, Li R. Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S100. PMID 27675525 DOI: 10.1016/J.Ijrobp.2016.06.249  1
2016 Anderson E, Filippi AR, Badellino S, Ricardi U, von Eyben R, Gensheimer MF, Diehn M, Loo BW, Shultz DB. Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: E485-E486. PMID 27674817 DOI: 10.1016/J.Ijrobp.2016.06.1848  1
2016 Shaffer J, Negahdar M, von Eyben R, Diehn M, Maxim PG, Loo BW. Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E460. PMID 27674752 DOI: 10.1016/J.Ijrobp.2016.06.1785  1
2016 Prionas ND, Aggarwal S, Shaffer J, von Eyben R, Graves EE, Maxim PG, Quon A, Gensheimer MF, Diehn M, Loo BW. Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E457. PMID 27674743 DOI: 10.1016/J.Ijrobp.2016.06.1777  1
2016 Binkley MS, King M, Bush K, Shrager JB, Chaudhuri AA, Popat R, Maxim PG, Guo HH, Diehn M, Nair VS, Loo BW. Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E456-E457. PMID 27674740 DOI: 10.1016/J.Ijrobp.2016.06.1776  1
2016 Qian Y, Pollom E, Durkee BY, von Eyben R, Gensheimer MF, Shultz DB, Diehn M, Loo BW. Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E422-E423. PMID 27674651 DOI: 10.1016/J.Ijrobp.2016.06.1692  1
2016 Carter JN, Aggarwal S, Radish K, Allen JR, Koong AC, Chang DT, Loo BW, Diehn M, Kunz PL, Gensheimer MF. Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E202-E203. PMID 27674052 DOI: 10.1016/J.Ijrobp.2016.06.1100  1
2016 Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, ... ... Diehn M, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. PMID 27663899 DOI: 10.1158/2159-8290.Cd-16-0127  1
2016 Cirujeda P, Cid Y, Muller H, Rubin D, Aguilera T, Loo B, Diehn M, Binefa X, Depeursinge A. A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT. Ieee Transactions On Medical Imaging. PMID 27429433 DOI: 10.1109/Tmi.2016.2591921  1
2016 Pollom EL, Qian Y, Durkee BY, von Eyben R, Maxim PG, Shultz DB, Gensheimer M, Diehn M, Loo BW. Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer. PMID 27378172 DOI: 10.1016/J.Cllc.2016.05.024  1
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, ... ... Diehn M, et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 11815. PMID 27283993 DOI: 10.1038/Ncomms11815  1
2016 Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, ... ... Diehn M, et al. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27267049 DOI: 10.1016/J.Radonc.2016.05.007  1
2016 Yang J, Yamamoto T, Pollock S, Berger J, Diehn M, Graves EE, Loo BW, Keall PJ. The impact of audiovisual biofeedback on 4D functional and anatomic imaging: Results of a lung cancer pilot study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27256597 DOI: 10.1016/J.Radonc.2016.05.016  1
2016 Wu J, Gensheimer MF, Dong X, Rubin DL, Napel S, Diehn M, Loo BW, Li R. Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics. PMID 27212196 DOI: 10.1016/J.Ijrobp.2016.03.018  1
2016 Wu J, Aguilera T, Shultz D, Gudur M, Rubin DL, Loo BW, Diehn M, Li R. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 151829. PMID 27046074 DOI: 10.1148/Radiol.2016151829  1
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Diehn M, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. PMID 27018799 DOI: 10.1038/Nbt.3520  1
2016 Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology (London, England). 11: 40. PMID 26975700 DOI: 10.1186/S13014-016-0616-8  1
2015 Binkley MS, Hiniker SM, Chaudhuri A, Maxim PG, Diehn M, Loo BW, Shultz DB. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation. International Journal of Radiation Oncology, Biology, Physics. PMID 26831903 DOI: 10.1016/J.Ijrobp.2015.12.007  1
2015 Myall NJ, Neal JW, Cho-Phan CD, Zhou LY, Stehr H, Zhou L, Diehn M, Wakelee HA. Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. Clinical Lung Cancer. PMID 26776917 DOI: 10.1016/J.Cllc.2015.12.001  1
2015 Cirujeda P, Muller H, Rubin D, Aguilera TA, Loo BW, Diehn M, Binefa X, Depeursinge A. 3D Riesz-wavelet based Covariance descriptors for texture classification of lung nodule tissue in CT. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2015: 7909-12. PMID 26738126 DOI: 10.1109/EMBC.2015.7320226  1
2015 Sun JG, Chen XW, Zhang LP, Wang J, Diehn M. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling. Oncotarget. PMID 26695440 DOI: 10.18632/oncotarget.6655  1
2015 Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology. 25: 305-12. PMID 26384278 DOI: 10.1016/J.Semradonc.2015.05.001  1
2015 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 107. PMID 26286589 DOI: 10.1093/Jnci/Djv211  1
2015 Westover KD, Loo BW, Gerber DE, Iyengar P, Choy H, Diehn M, Hughes R, Schiller J, Dowell J, Wardak Z, Sher D, Christie A, Xie XJ, Corona I, Sharma A, et al. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics. 93: 72-81. PMID 26279026 DOI: 10.1016/J.Ijrobp.2015.05.004  1
2015 Yu AS, von Eyben R, Yamamoto T, Diehn M, Shultz DB, Loo BW, Maxim PG. Anatomic optimization of lung tumor stereotactic ablative radiation therapy. Practical Radiation Oncology. PMID 26231596 DOI: 10.1016/J.Prro.2015.05.008  1
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 21: 938-45. PMID 26193342 DOI: 10.1038/Nm.3909  1
2015 Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW, Shultz DB, Diehn M. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 26025776 DOI: 10.1016/J.Ijrobp.2015.04.004  1
2015 Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer (Amsterdam, Netherlands). 89: 50-6. PMID 25997421 DOI: 10.1016/J.Lungcan.2015.04.014  1
2015 King MT, Maxim PG, Diehn M, Loo BW, Xing L. Analysis of Long-Term 4-Dimensional Computed Tomography Regional Ventilation After Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 92: 683-90. PMID 25936813 DOI: 10.1016/J.Ijrobp.2015.02.037  1
2015 Jeong Y, Swami S, Krishnan AV, Williams JD, Martin S, Horst RL, Albertelli MA, Feldman BJ, Feldman D, Diehn M. Inhibition of Mouse Breast Tumor Initiating Cells by Calcitriol and Dietary Vitamin D. Molecular Cancer Therapeutics. PMID 25934710 DOI: 10.1158/1535-7163.Mct-15-0066  1
2015 Jeong Y, Rhee H, Martin S, Klass D, Lin Y, Nguyen LX, Feng W, Diehn M. Identification and genetic manipulation of human and mouse oesophageal stem cells. Gut. PMID 25897018 DOI: 10.1136/Gutjnl-2014-308491  1
2015 Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, ... ... Diehn M, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 125: 3679-87. PMID 25887775 DOI: 10.1182/Blood-2015-03-635169  1
2015 Negahdar M, Fasola CE, Yu AS, von Eyben R, Yamamoto T, Diehn M, Fleischmann D, Tian L, Loo BW, Maxim PG. Noninvasive pulmonary nodule elastometry by CT and deformable image registration. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 115: 35-40. PMID 25824979 DOI: 10.1016/J.Ijrobp.2014.05.1857  1
2015 Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 12: 453-7. PMID 25822800 DOI: 10.1038/Nmeth.3337  1
2015 Bratman SV, Newman AM, Alizadeh AA, Diehn M. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq. Expert Review of Molecular Diagnostics. 15: 715-9. PMID 25773944 DOI: 10.1586/14737159.2015.1019476  1
2015 Shultz DB, Diehn M, Loo BW. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer. Seminars in Radiation Oncology. 25: 78-86. PMID 25771411 DOI: 10.1016/J.Semradonc.2014.11.005  1
2015 Yom SS, Diehn M, Raben D. Molecular determinants of radiation response in non-small cell lung cancer. Seminars in Radiation Oncology. 25: 67-77. PMID 25771410 DOI: 10.1016/J.Semradonc.2014.12.007  1
2015 Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW. Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clinical Lung Cancer. PMID 25770888 DOI: 10.1016/J.Cllc.2015.01.007  1
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Yue X, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr09  1
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers Nature Medicine. 21: 938-945. DOI: 10.1038/nm.3909  1
2015 Say C, Diehn M, Loo BW, Shultz DB. Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1660  1
2015 Chaudhuri AA, Binkley MS, Diehn M. Cancer stem cells and tumor radioresistance Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. 519-531. DOI: 10.1007/978-3-319-21030-8_18  1
2014 Kuo P, Bratman SV, Shultz DB, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia AJ, Koong AC, Diehn M, Le QT. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5558-69. PMID 25189484 DOI: 10.1158/1078-0432.Ccr-14-1138  1
2014 Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M, Alizadeh AA. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics (Oxford, England). 30: 3390-3. PMID 25143292 DOI: 10.1093/Bioinformatics/Btu549  1
2014 Yamamoto T, Kabus S, Lorenz C, Mittra E, Hong JC, Chung M, Eclov N, To J, Diehn M, Loo BW, Keall PJ. Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. International Journal of Radiation Oncology, Biology, Physics. 90: 414-22. PMID 25104070 DOI: 10.1016/J.Ijrobp.2014.06.006  1
2014 Xiao N, Lin Y, Cao H, Sirjani D, Giaccia AJ, Koong AC, Kong CS, Diehn M, Le QT. Neurotrophic factor GDNF promotes survival of salivary stem cells. The Journal of Clinical Investigation. 124: 3364-77. PMID 25036711 DOI: 10.1172/Jci74096  1
2014 Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics. 90: 216-23. PMID 25015205 DOI: 10.1016/J.Ijrobp.2014.05.025  1
2014 Shultz DB, Trakul N, Maxim PG, Diehn M, Loo BW. Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest. Practical Radiation Oncology. 4: 272-8. PMID 25012837 DOI: 10.1016/J.Prro.2013.08.005  1
2014 Moré JM, Eclov NC, Chung MP, Wynne JF, Shorter JH, Nelson DD, Hanlon AL, Burmeister R, Banos P, Maxim PG, Loo BW, Diehn M. Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 957-64. PMID 24926543 DOI: 10.1097/Jto.0000000000000182  1
2014 Shultz DB, Jang SS, Hanlon AL, Diehn M, Loo BW, Maxim PG. The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy. Practical Radiation Oncology. 4: 192-7. PMID 24766687 DOI: 10.1016/J.Prro.2013.07.010  1
2014 Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Medicine. 20: 548-54. PMID 24705333 DOI: 10.1038/Nm.3519  1
2014 Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW, Diehn M. Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clinical Lung Cancer. 15: 294-301.e3. PMID 24594400 DOI: 10.1016/J.Cllc.2013.12.011  1
2014 Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells (Dayton, Ohio). 32: 1734-45. PMID 24497069 DOI: 10.1002/Stem.1662  1
2014 Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW, Diehn M. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 872-84. PMID 24495591 DOI: 10.1016/J.Ijrobp.2013.12.010  1
2014 Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, Fan C, Murphy L, Lee CY, Troester MA, Miller CR, Jin J, Darr D, Perou CM, Levine RL, ... Diehn M, et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. The Journal of Clinical Investigation. 124: 553-63. PMID 24435044 DOI: 10.1172/Jci69804  1
2014 Lee CY, Lin Y, Bratman SV, Feng W, Kuo AH, Scheeren FA, Engreitz JM, Varma S, West RB, Diehn M. Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. Cancer Research. 74: 341-52. PMID 24177178 DOI: 10.1158/0008-5472.Can-13-1055  1
2014 Jamshidi N, Diehn M, Bredel M, Kuo MD. Illuminating radiogenomic characteristics of glioblastoma multiforme through integration of MR imaging, messenger RNA expression, and DNA copy number variation. Radiology. 270: 1-2. PMID 24056404 DOI: 10.1148/Radiol.13130078  1
2014 Chaudhuri AA, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Abstract 864: Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors Cancer Research. 74: 864-864. DOI: 10.1158/1538-7445.Am2014-864  1
2014 Kuo P, Bratman S, Shultz D, Eyben Rv, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia A, Koong A, Diehn M, Le Q. Abstract 848: Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response Cancer Research. 74: 848-848. DOI: 10.1158/1538-7445.Am2014-848  1
2014 Bratman SV, Diehn M. Lung Cancer Stem Cells and Resistance to Radiotherapy Cancer Stem Cells. 171-182. DOI: 10.1002/9781118356203.ch13  1
2013 Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW. Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Practical Radiation Oncology. 3: 294-300. PMID 24674401 DOI: 10.1016/J.Prro.2012.09.003  1
2013 Li R, Han B, Meng B, Maxim PG, Xing L, Koong AC, Diehn M, Loo BW. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 87: 917-23. PMID 24113060 DOI: 10.1016/J.Ijrobp.2013.08.015  1
2013 Yamamoto T, Kabus S, Lorenz C, Johnston E, Maxim PG, Diehn M, Eclov N, Barquero C, Loo BW, Keall PJ. 4D CT lung ventilation images are affected by the 4D CT sorting method. Medical Physics. 40: 101907. PMID 24089909 DOI: 10.1118/1.4820538  1
2013 Hong JC, Eclov NC, Yu Y, Rao AK, Dieterich S, Le QT, Diehn M, Sze DY, Loo BW, Kothary N, Maxim PG. Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 14: 4046. PMID 23470933 DOI: 10.1120/Jacmp.V14I2.4046  1
2013 Shultz DB, Grecula JC, Hayman J, Diehn M, Loo BW. The optimal use of radiotherapy in small cell lung cancer Jnccn Journal of the National Comprehensive Cancer Network. 11: 107-114. DOI: 10.6004/Jnccn.2013.0013  1
2013 Green MR, Bratman S, Liu CL, Takahashi K, Glover C, Keane C, Kihira S, Kong K, Faham M, Karen C, Miklos DB, Advani RH, Levy R, Hertzberg MS, Frcpa, ... ... Diehn M, et al. Utility Of Non-Invasive Monitoring Of Circulating Tumor DNA At Diagnosis, Interim Therapy, and Relapse Of DLBCL Using High-Throughput Sequencing Of Immunoglobulin Genes Blood. 122: 4264-4264. DOI: 10.1182/Blood.V122.21.4264.4264  1
2013 Dalerba P, Clarke MF, Weissman IL, Diehn M. Stem Cells, Cell Differentiation, and Cancer Abeloff's Clinical Oncology: Fifth Edition. 98-107.e5. DOI: 10.1016/B978-1-4557-2865-7.00007-2  1
2013 Yalunin SV, Herink G, Solli DR, Krüger M, Hommelhoff P, Diehn M, Munk A, Ropers C. Field localization and rescattering in tip-enhanced photoemission Annalen Der Physik. 525: L12-L18. DOI: 10.1002/Andp.201200224  1
2013 Müller R, Birke T, Diehn M, Engel D, Franksen B, Görgen R, Kuske P, Lange R, Müller I, Schälicke A, Schindhelm G. Fast orbit feedback at BESSY-II: Performance and operational experiences Ipac 2013: Proceedings of the 4th International Particle Accelerator Conference. 2920-2922.  1
2012 Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer (Amsterdam, Netherlands). 78: 219-24. PMID 23009727 DOI: 10.1016/J.Lungcan.2012.08.016  1
2012 Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1462-5. PMID 22895143 DOI: 10.1097/Jto.0B013E31825F22Ce  1
2012 Li R, Mok E, Chang DT, Daly M, Loo BW, Diehn M, Le QT, Koong A, Xing L. Intrafraction verification of gated RapidArc by using beam-level kilovoltage X-ray images. International Journal of Radiation Oncology, Biology, Physics. 83: e709-15. PMID 22554582 DOI: 10.1016/J.Ijrobp.2012.03.006  1
2012 Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, ... ... Diehn M, et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. International Journal of Radiation Oncology, Biology, Physics. 84: 231-7. PMID 22381907 DOI: 10.1016/J.Ijrobp.2011.10.071  1
2011 Terezakis SA, Heron DE, Lavigne RF, Diehn M, Loo BW. What the diagnostic radiologist needs to know about radiation oncology. Radiology. 261: 30-44. PMID 21931140 DOI: 10.1148/Radiol.11101688  1
2011 Johnston E, Diehn M, Murphy JD, Loo BW, Maxim PG. Reducing 4D CT artifacts using optimized sorting based on anatomic similarity. Medical Physics. 38: 2424-9. PMID 21776777 DOI: 10.1118/1.3577601  1
2011 Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, et al. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 920-6. PMID 21774104 DOI: 10.1097/Jto.0B013E31821517Db  1
2011 Hong JC, Yu Y, Rao AK, Dieterich S, Maxim PG, Le QT, Diehn M, Sze DY, Kothary N, Loo BW. High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. International Journal of Radiation Oncology, Biology, Physics. 81: 85-90. PMID 20675070 DOI: 10.1016/J.Ijrobp.2010.04.037  1
2011 Liu MB, Eclov N, Trakul N, Diehn M, Maxim PG, Dieterich S, Loo BW. Ray-trace Calculation Significantly Overestimates Dose Compared To Monte Carlo Calculation In CyberKnife Stereotactic Ablative Radiotherapy Of Lung Tumors International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1514  1
2011 Brown M, Loo BW, Diehn M, Carlson DJ. In reply to Song et al. International Journal of Radiation Oncology Biology Physics. 81: 1194. DOI: 10.1016/J.Ijrobp.2011.05.023  1
2011 Brown M, Loo B, Diehn M, Carlson D. Influence of tumor hypoxia on Stereotactic Ablative Radiotherapy (SABR): Response to Drs. Meyer and Timmerman International Journal of Radiation Oncology Biology Physics. 79: 1600. DOI: 10.1016/J.Ijrobp.2010.11.013  1
2010 Rothenberg ME, Clarke MF, Diehn M. The Myc connection: ES cells and cancer. Cell. 143: 184-6. PMID 20946977 DOI: 10.1016/J.Cell.2010.09.046  1
2010 Brown JM, Diehn M, Loo BW. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. International Journal of Radiation Oncology, Biology, Physics. 78: 323-7. PMID 20832663 DOI: 10.1016/J.Ijrobp.2010.04.070  1
2010 Diehn M, Majeti R. Metastatic cancer stem cells: an opportunity for improving cancer treatment? Cell Stem Cell. 6: 502-3. PMID 20569685 DOI: 10.1016/J.Stem.2010.05.001  1
2009 Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 14016-21. PMID 19666525 DOI: 10.1073/Pnas.0906549106  1
2009 Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K, Clarke MF. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 138: 592-603. PMID 19665978 DOI: 10.1016/J.Cell.2009.07.011  1
2009 Diehn M, Cho RW, Clarke MF. Therapeutic implications of the cancer stem cell hypothesis. Seminars in Radiation Oncology. 19: 78-86. PMID 19249645 DOI: 10.1016/J.Semradonc.2008.11.002  1
2009 Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 458: 780-3. PMID 19194462 DOI: 10.1038/Nature07733  1
2008 Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences of the United States of America. 105: 5213-8. PMID 18362333 DOI: 10.1073/Pnas.0801279105  1
2008 Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells (Dayton, Ohio). 26: 364-71. PMID 17975224 DOI: 10.1634/Stemcells.2007-0440  1
2008 Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. Journal of Neuro-Oncology. 86: 133-41. PMID 17653508 DOI: 10.1007/S11060-007-9457-5  1
2006 Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. Journal of the National Cancer Institute. 98: 1755-7. PMID 17179471 DOI: 10.1093/Jnci/Djj505  1
2006 Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Bmc Genomics. 7: 115. PMID 16704732 DOI: 10.1186/1471-2164-7-115  1
2006 Diehn M, Bhattacharya R, Botstein D, Brown PO. Genome-scale identification of membrane-associated human mRNAs. Plos Genetics. 2: e11. PMID 16415983 DOI: 10.1371/Journal.Pgen.0020011  1
2005 Diehn JJ, Diehn M, Marmor MF, Brown PO. Differential gene expression in anatomical compartments of the human eye. Genome Biology. 6: R74. PMID 16168081 DOI: 10.1016/J.Ajo.2006.08.015  1
2005 Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 102: 5814-9. PMID 15827123 DOI: 10.1073/Pnas.0402870102  1
2004 Tu IP, Schaner M, Diehn M, Sikic BI, Brown PO, Botstein D, Fero MJ. A method for detecting and correcting feature misidentification on expression microarrays. Bmc Genomics. 5: 64. PMID 15357875 DOI: 10.1186/1471-2164-5-64  1
2004 Piedras-Rentería ES, Pyle JL, Diehn M, Glickfeld LL, Harata NC, Cao Y, Kavalali ET, Brown PO, Tsien RW. Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. Proceedings of the National Academy of Sciences of the United States of America. 101: 3609-14. PMID 14990796 DOI: 10.1073/Pnas.0308188100  1
2003 Roose JP, Diehn M, Tomlinson MG, Lin J, Alizadeh AA, Botstein D, Brown PO, Weiss A. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. Plos Biology. 1: E53. PMID 14624253 DOI: 10.1371/Journal.Pbio.0000053  1
2003 Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, et al. Gene expression patterns in ovarian carcinomas. Molecular Biology of the Cell. 14: 4376-86. PMID 12960427 DOI: 10.1091/Mbc.E03-05-0279  1
2003 Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proceedings of the National Academy of Sciences of the United States of America. 100: 1896-901. PMID 12578971 DOI: 10.1073/Pnas.252784499  1
2003 Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Research. 31: 219-23. PMID 12519986 DOI: 10.1093/Nar/Gkg014  1
2002 Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 99: 11796-801. PMID 12195013 DOI: 10.1073/Pnas.092284399  1
2002 DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biology. 3: RESEARCH0032. PMID 12184806 DOI: 10.1186/Gb-2002-3-7-Research0032  1
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. Bmc Immunology. 3: 5. PMID 12079505 DOI: 10.1186/1471-2172-3-5  1
2002 Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 8886-91. PMID 12077300 DOI: 10.1073/Pnas.132253599  1
2002 Clément K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research. 12: 281-91. PMID 11827947 DOI: 10.1101/Gr.207702  1
2002 Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 972-7. PMID 11805339 DOI: 10.1073/Pnas.231625398  1
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fcε RI and identification of mast cells as a source of IL-11 Bmc Immunology. 3. DOI: 10.1186/1471-2172-3-5  1
2001 Diehn M, Relman DA. Comparing functional genomic datasets: lessons from DNA microarray analyses of host-pathogen interactions. Current Opinion in Microbiology. 4: 95-101. PMID 11173041 DOI: 10.1016/S1369-5274(00)00171-5  1
2000 Casagrande R, Stern P, Diehn M, Shamu C, Osario M, Zúñiga M, Brown PO, Ploegh H. Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway. Molecular Cell. 5: 729-35. PMID 10882108 DOI: 10.1016/S1097-2765(00)80251-8  1
2000 Diehn M, Alizadeh AA, Brown PO. Examining the living genome in health and disease with DNA microarrays. Jama. 283: 2298-9. PMID 10807394 DOI: 10.1001/Jama.283.17.2298-Jms0503-4-1  1
2000 Diehn M, Eisen MB, Botstein D, Brown PO. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nature Genetics. 25: 58-62. PMID 10802657 DOI: 10.1038/75603  1
2000 Bunnell SC, Diehn M, Yaffe MB, Findell PR, Cantley LC, Berg LJ. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. The Journal of Biological Chemistry. 275: 2219-30. PMID 10636929 DOI: 10.1074/Jbc.275.3.2219  1
Show low-probability matches.